Evidence quality 4.0/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 3/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 3/5
- D5 Scope
- 4/5
- D6 Prose
- 4/5
- D7 Perception honesty
- 3/5
- D8 Caveat completeness
- 5/5
● your factors — click this risk ▾ to reveal
- Your factors
≈ As likely as
Perceived
Typhoid fever occupies a strange position in the popular imagination of wealthy countries: it is strongly associated with the past, with Mary Mallon and Victorian-era sanitation failures, rather than with the present. The availability of clean water, modern sewage systems, and antibiotics has reduced typhoid to a handful of travel-associated cases per year in the US and Europe, reinforcing the perception that it is a historical disease. In South Asia, Southeast Asia, and parts of sub-Saharan Africa, typhoid remains a major killer, causing an estimated 130,000 deaths per year among populations without reliable access to safe water and sanitation. The gap between historical perception and current endemic reality is one of the widest in infectious disease.
Source: editorial intuition, not polled
Actual
~130,000 deaths per year globally from typhoid and paratyphoid fever
global adults and children
Show derivation
Native rate: The 130,000-deaths central estimate is a rounded cross-source value for annual global enteric-fever (typhoid and paratyphoid) deaths, bracketed by the WHO fact sheet's ~110,000 (2019), the GBD 2021 systematic analysis's 107.5 thousand (95% UI 56.1-180.8; eClinicalMedicine, below), and the standalone GBD 2017 estimate of 135,900 deaths (95% UI 76,900-218,900; Lancet Infectious Diseases, below). Against a global adult population of ~5 billion: 130,000 / 5,000,000,000 = 0.000026. Lifetime conversion: 1 - (1 - 0.000026)^59 = 0.00153. Uncertainty low bound uses 80,000 deaths (near the GBD 2017 lower UI of 76,900, reflecting declining trends and improved treatment access); high bound uses 161,000, a conservative figure well inside the GBD 2017 upper UI of 218,900. Low: 80,000/5B compounded 59 years = 0.00094. High: 161,000/5B compounded 59 years = 0.0019. The burden is concentrated in South Asia (particularly India, Pakistan, and Bangladesh), Southeast Asia, and sub-Saharan Africa. For any adult in a high-income country with modern water treatment and sanitation, personal typhoid mortality risk is negligible.
Caveats: The 1-in-650 global lifetime figure is driven almost entirely by populations in …
The 1-in-650 global lifetime figure is driven almost entirely by populations in South Asia, Southeast Asia, and sub-Saharan Africa without reliable access to safe water, modern sanitation, and effective antibiotics. For any adult in a high-income country with treated water and sewage infrastructure, the personal probability of dying from typhoid is negligible — the US reports fewer than 5 typhoid deaths per year, almost all in returned travellers. Antimicrobial resistance is a growing concern: extensively drug-resistant (XDR) typhoid strains have emerged in Pakistan and spread to other endemic regions, potentially increasing case fatality rates in settings where second-line antibiotics are unavailable. Typhoid conjugate vaccines (TCVs) recommended by WHO since 2018 are being introduced in endemic countries but coverage remains limited. Children bear a disproportionate share of both morbidity and mortality.
Related risks
Other risks on similar themes — for exploring related fears.
Heat stroke (outdoor)
What are the odds of dying from heat stroke or severe heat illness during outdoor activity?
Unsafe imported products
What are the odds of being harmed by an unsafe imported consumer product?
Childhood cancer diagnosis
What are the odds of a child being diagnosed with cancer before age 20?
Counterfeit medicine
What are the odds of being harmed or killed by a counterfeit or substandard medicine?
COVID-19
What are the odds of dying from COVID-19 over the course of the pandemic and endemic era?
Pick challenger
Typhoid fever, caused by the bacterium Salmonella enterica serovar Typhi and transmitted through contaminated water and food, kills roughly 130,000 people per year globally — a rounded central figure bracketed by the major burden-of-disease estimates. The GBD 2021 systematic analysis published in eClinicalMedicine estimated 9.3 million cases (95% uncertainty interval 7.3 to 11.9 million) and 107,500 deaths (95% UI 56,100 to 180,800) for 2021; the standalone GBD 2017 study put deaths at 135,900 (95% UI 76,900 to 218,900); and WHO’s 2019-based fact sheet gives ~9 million cases and about 110,000 deaths per year. The burden is overwhelmingly concentrated in South Asia, Southeast Asia, and parts of sub-Saharan Africa, where inadequate water treatment and sanitation infrastructure create persistent transmission cycles. India, Pakistan, and Bangladesh bear the largest share of global typhoid mortality. The case fatality rate without treatment exceeds 10%; with appropriate antibiotics it drops below 1%, making access to healthcare the critical determinant of survival.
The perception gap is shaped by history and geography. In high-income countries, typhoid is a disease of the 19th century: Typhoid Mary, cholera-era London, the sanitation revolution. Modern water treatment and sewage systems have reduced domestic transmission to near zero, and the handful of annual cases are almost exclusively travellers returning from endemic regions. The result is a population that classifies typhoid alongside smallpox and plague as threats that medicine has already defeated. In reality, the disease kills more people per year than many hazards that receive substantially more public attention, and the emergence of extensively drug-resistant (XDR) typhoid strains in Pakistan is actively worsening the outlook. XDR strains are resistant to all first-line oral antibiotics, leaving only injectable carbapenems and azithromycin, neither of which is readily available in the rural clinics where most patients present.
Where the number does not apply: any person living in a country with modern water treatment, sewage infrastructure, and universal antibiotic access is operating outside the risk distribution that generates the 1-in-650 global lifetime figure. The US reports fewer than 5 typhoid deaths per year. WHO-recommended typhoid conjugate vaccines (TCVs) are being introduced in endemic countries and have demonstrated strong efficacy in clinical trials, but rollout remains incomplete. The declining trend in global typhoid deaths — the GBD 2021 analysis puts its most recent (2021) figure at 107,500 deaths, down from a higher 2017 estimate — reflects improvements in water and sanitation infrastructure, but progress is uneven, and population growth in high-burden regions partially offsets per-capita gains.
Related tidbits
Typhoid and paratyphoid fever cause about 130,000 deaths a year globally, a lifetime risk near 1 in 650 for a global adult. The burden sits almost entirely in regions with unsafe water and limited sanitation.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] World Health Organization — Typhoid — Fact sheet
Typhoid — Fact sheet- Statistic
As of 2019 estimates, ~9 million typhoid cases annually, resulting in about 110,000 deaths per year- Excerpt
“"As of 2019 estimates, there are 9 million cases of typhoid fever annually, resulting in about 110 000 deaths per year. Typhoid risk is higher in populations that lack access to safe water and adequate sanitation, and children are at highest risk." ”
- Source data from
- 2024-03-01
- Accessed
- 2026-04-24 · archived copy
- Calculation
- The WHO fact sheet gives ~9 million cases and about 110,000 deaths per year (2019 estimates). The 130,000 central estimate used for the native numerator is a rounded cross-source value bracketed by the three burden-of-disease estimates cited here: WHO's ~110,000 (2019), the GBD 2021 analysis's 107.5 thousand (2021) and higher 2017 figure, and the standalone GBD 2017 study's 135,900 (eClinicalMedicine and Lancet Infectious Diseases, below). 130,000 / 5B = 0.000026 annual rate, compounded over 59 years yields 0.00153.
-
[2] eClinicalMedicine (The Lancet) — The global burden of enteric fever, 2017-2021: a systematic analysis from the global burden of disease study 2021
The global burden of enteric fever, 2017-2021: a systematic analysis from the global burden of disease study 2021- Statistic
For 2021, an estimated 9.3 million global cases of enteric fever (95% UI 7.3-11.9) and 107.5 thousand deaths (95% UI 56.1-180.8); burden concentrated in 75 endemic countries- Excerpt
“"9.3 million global cases of enteric fever (95% uncertainty interval: 7.3−11.9) [...] 107.5 thousand deaths (56.1−180.8)." ”
- Source data from
- 2024-10-01
- Accessed
- 2026-04-24 · archived copy
- Calculation
- The GBD 2021 systematic analysis estimates 9.3 million cases (95% UI 7.3-11.9) and 107.5 thousand deaths (95% UI 56.1-180.8) for 2021, and a higher 2017 figure — the source of the well-documented decline. This confirms the same order of magnitude as the WHO fact sheet (~110,000 deaths) and the standalone GBD 2017 study (135,900 deaths). The 130,000 central native numerator is a rounded cross-source value bracketed by these estimates, not this study's own 2021 headline. The study integrates antimicrobial resistance data, increasingly relevant as drug-resistant strains spread in South Asia.
-
[3] The Lancet Infectious Diseases — The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017
The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017- Statistic
Typhoid and paratyphoid fevers caused an estimated 135,900 deaths globally in 2017; children had the highest morbidity and mortality rates- Excerpt
“"Typhoid and paratyphoid fevers remain important causes of morbidity and mortality. Children had the highest morbidity and mortality rates; males had higher rates of incidence, mortality, and DALYs than females. The burden is concentrated in South Asia, Southeast Asia, and Oceania." ”
- Source data from
- 2019-04-01
- Accessed
- 2026-04-24 · archived copy
- Calculation
- The GBD 2017 estimate of 135,900 deaths provides an independent temporal data point consistent with the 130,000 central estimate. Confirms the demographic pattern (children most affected, males disproportionately) and the geographic concentration in South Asia. The decline from 135,900 (2017) toward 130,000 (2021) is consistent with the gradual reduction observed in the GBD trend analysis.
-
[4] US Centers for Disease Control and Prevention — Clinical Guidance for Typhoid Fever and Paratyphoid Fever
Clinical Guidance for Typhoid Fever and Paratyphoid Fever- Statistic
Case fatality rate for untreated typhoid fever was higher than 10% before widespread antibiotic use; with appropriate treatment the fatality rate is lower than 1%- Excerpt
“"Before widespread antibiotic use, the case fatality rate for typhoid fever was higher than 10%. [...] With appropriate treatment, the fatality rate of typhoid fever is lower than 1%." ”
- Source data from
- 2025-01-16
- Accessed
- 2026-07-04 · archived copy
- Calculation
- Grounds the body-text claim that untreated typhoid case fatality "exceeds 10%" and drops "below 1%" with appropriate antibiotics — this is a per-patient case-fatality contrast, not a population-level death count, so it does not change the 130,000-deaths/year headline. It explains why access to healthcare is described as the critical determinant of survival.
- Independence
- CDC clinical guidance for practitioners, independent of the WHO fact sheet and the two GBD burden-of-disease studies above, which report population-level case and death counts rather than per-patient case fatality rates.